Prognostic Parameters for the Primary Care of Melanoma Patients: What Is Really Risky in Melanoma?
Due to intensified research in recent years, the understanding of the molecular mechanisms involved in the development of melanoma has dramatically improved. The discovery of specific, causal mutations such as BRAF or KIT oncogenes not only renders a targeted and thus more effective therapeutic appr...
Saved in:
Main Authors: | Daniela Göppner, Martin Leverkus |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Journal of Skin Cancer |
Online Access: | http://dx.doi.org/10.1155/2011/521947 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prognostic Value of Melanoma Inhibitory Activity Protein in Localized Cutaneous Malignant Melanoma
by: Angela Sandru, et al.
Published: (2014-01-01) -
Mortality Prognostic Factors in Patients with Cutaneous Malignant Melanoma
by: Víctor Ernesto González Velázquez, et al.
Published: (2021-01-01) -
Primary adrenal malignant melanoma
by: Xiaoli Guan, et al.
Published: (2023-07-01) -
Erratum to “Primary Desmoplastic Melanoma of the Penis”
by: Julia T. Chu, et al.
Published: (2016-01-01) -
Clinical Characteristics of Cutaneous Melanoma and Second Primary Malignancies in a Dutch Hospital-Based Cohort of Cutaneous Melanoma Patients
by: Haike M. J. van der Velden, et al.
Published: (2009-01-01)